Regenxbio Sets Sights On 2026 Filing For DMD Gene Therapy
The company has reached agreement with the US FDA on a pivotal trial for RGX-202 through an accelerated pathway.
The company has reached agreement with the US FDA on a pivotal trial for RGX-202 through an accelerated pathway.